Skip to main content

Revance Therapeutics, Inc. - Common Stock (NQ: RVNC )

3.080 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
May 10, 2018
Form 4
Source: SEC/Edgar
May 10, 2018
Form 4
Source: SEC/Edgar
May 10, 2018
Form 4
Source: SEC/Edgar
May 10, 2018
Form 3
Source: SEC/Edgar
May 02, 2018
Form 4
Source: SEC/Edgar
May 02, 2018
Form 4
Source: SEC/Edgar
March 15, 2018
Form 4
Source: SEC/Edgar
March 15, 2018
Form 4
Source: SEC/Edgar
March 15, 2018
Form 4
Source: SEC/Edgar
March 08, 2018
Form 4
Source: SEC/Edgar
March 08, 2018
Form 4
Source: SEC/Edgar
February 15, 2018
Form 4
Source: SEC/Edgar
February 15, 2018
Form 4
Source: SEC/Edgar
February 15, 2018
Form 4
Source: SEC/Edgar
February 08, 2018
Form 4
Source: SEC/Edgar
February 08, 2018
Form 4
Source: SEC/Edgar
February 08, 2018
Form 4
Source: SEC/Edgar
February 08, 2018
Form 4
Source: SEC/Edgar
January 29, 2018
Form 4
Source: SEC/Edgar
January 02, 2018
Form 4
Source: SEC/Edgar
January 02, 2018
Form 4
Source: SEC/Edgar
December 27, 2017
Form 4
Source: SEC/Edgar
December 17, 2017
Form 4
Source: SEC/Edgar
November 23, 2017
Form 4
Source: SEC/Edgar
October 19, 2017
Form 4
Source: SEC/Edgar
September 21, 2017
Form 3
Source: SEC/Edgar
September 19, 2017
Form 4
Source: SEC/Edgar
September 19, 2017
Form 4
Source: SEC/Edgar
September 06, 2017
Form 3
Source: SEC/Edgar
September 06, 2017
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.